Uncontrolled aggregation of amyloid beta peptide (Aβ) is the main cause of Alzheimer's disease. Therapeutic approaches to intervention in amyloid diseases include the use of small molecules able to stabilize the soluble Aβ conformation, or to redirect the amyloidogenic pathway towards non-toxic and non-fibrillar states. Fluorometric measurements revealed that 3-(4′-trifluoromethylphenyl)-5-(4′-methoxyphenyl)-1,2,4-oxadiazole, when irradiated, is able to interact with the monomeric Aβ peptide readdressing the aggregation pathway toward the formation of amorphous aggregates as evidenced by CD, AFM, and SAXS measurements. We hypothesize that this compound, under radiation, forms a reactive intermediate that sticks on the Aβ peptide by interfering with its fibrillation process. Cytotoxicity assays performed on LAN5 neuroblastoma cells suggest that the presence of oxadiazole reduces the toxicity of Aβ. This finding might be the start of innovative therapies against Alzheimer's disease.

Mangione M.R., Palumbo Piccionello A., Marino C., Ortore M.G., Picone P., Vilasi S., et al. (2015). Photo-inhibition of Aβ fibrillation mediated by a newly designed fluorinated oxadiazole. RSC ADVANCES, 5(21), 16540-16548 [10.1039/c4ra13556c].

Photo-inhibition of Aβ fibrillation mediated by a newly designed fluorinated oxadiazole

Mangione M. R.;Palumbo Piccionello A.
;
Marino C.;Buscemi S.;San Biagio P. L.
2015-01-01

Abstract

Uncontrolled aggregation of amyloid beta peptide (Aβ) is the main cause of Alzheimer's disease. Therapeutic approaches to intervention in amyloid diseases include the use of small molecules able to stabilize the soluble Aβ conformation, or to redirect the amyloidogenic pathway towards non-toxic and non-fibrillar states. Fluorometric measurements revealed that 3-(4′-trifluoromethylphenyl)-5-(4′-methoxyphenyl)-1,2,4-oxadiazole, when irradiated, is able to interact with the monomeric Aβ peptide readdressing the aggregation pathway toward the formation of amorphous aggregates as evidenced by CD, AFM, and SAXS measurements. We hypothesize that this compound, under radiation, forms a reactive intermediate that sticks on the Aβ peptide by interfering with its fibrillation process. Cytotoxicity assays performed on LAN5 neuroblastoma cells suggest that the presence of oxadiazole reduces the toxicity of Aβ. This finding might be the start of innovative therapies against Alzheimer's disease.
Mangione M.R., Palumbo Piccionello A., Marino C., Ortore M.G., Picone P., Vilasi S., et al. (2015). Photo-inhibition of Aβ fibrillation mediated by a newly designed fluorinated oxadiazole. RSC ADVANCES, 5(21), 16540-16548 [10.1039/c4ra13556c].
File in questo prodotto:
File Dimensione Formato  
C4RA13556C.pdf

Solo gestori archvio

Tipologia: Pre-print
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/442761
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact